These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2797472)

  • 1. Cognition in Parkinson's disease.
    Braham J; Sadeh M; Modan M
    Neurology; 1989 Oct; 39(10):1411. PubMed ID: 2797472
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep brain stimulation and cognition in Parkinson's disease: an eight-year follow-up study.
    Zangaglia R; Pasotti C; Mancini F; Servello D; Sinforiani E; Pacchetti C
    Mov Disord; 2012 Aug; 27(9):1192-4. PubMed ID: 22700367
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between neuropsychiatric symptoms and cognitive performance in de novo Parkinson's disease.
    Poletti M; Lucetti C; Del Dotto P; Berti C; Logi C; Bonuccelli U
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E22-3. PubMed ID: 23224469
    [No Abstract]   [Full Text] [Related]  

  • 5. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Serrano-Dueñas M; Calero B; Serrano S; Serrano M; Coronel P
    Mov Disord; 2010 Nov; 25(15):2555-62. PubMed ID: 20824734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age of disease onset influences cognition in Parkinson's disease.
    Katzen HL; Levin BE; Llabre ML
    J Int Neuropsychol Soc; 1998 May; 4(3):285-90. PubMed ID: 9623003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution and profile of dementia in Parkinson's disease.
    Ross HF; Hughes TA; Boyd JL; Biggins CA; Madeley P; Mindham RH; Spokes EG
    Adv Neurol; 1996; 69():343-7. PubMed ID: 8615150
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural and psychological symptoms of dementia associated with Parkinson's disease.
    Leroi I; Burns A
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):2-3. PubMed ID: 16954135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. French consensus procedure for assessing cognitive function in Parkinson's disease.
    Dujardin K; Auzou N; Lhommée E; Czernecki V; Dubois B; Fradet A; Maltete D; Meyer M; Pineau F; Schmitt E; Sellal F; Tison F; Vidal T; Azulay JP; Welter ML; Corvol JC; Durif F; Rascol O;
    Rev Neurol (Paris); 2016 Nov; 172(11):696-702. PubMed ID: 27318613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease.
    Armstrong MJ; Duff-Canning S; Tang-Wai DF; Fox S; Zadikoff C; Kennedy N; Gill D; Eslinger PJ; Mapstone M; Chou KL; Persad C; Litvan I; Mast BT; Marras C
    Parkinsonism Relat Disord; 2013 Apr; 19(4):463-5. PubMed ID: 23036511
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of the neuropsychologist in Parkinson's disease].
    Montillot J
    Soins; 2024 Mar; 69(883):42-45. PubMed ID: 38453400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apathy in Parkinson's disease].
    García-Ramos R; Villanueva C; del Val J; Matías-Guíu J
    Neurologia; 2010; 25(1):40-50. PubMed ID: 20388460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analytic comparison of the components of visual cognition in Parkinson's disease.
    Waterfall ML; Crowe SF
    J Clin Exp Neuropsychol; 1995 Oct; 17(5):759-72. PubMed ID: 8557816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Effects of Rasagiline in Mild-to-Moderate Stage Parkinson's Disease Without Dementia.
    Frakey LL; Friedman JH
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):22-25. PubMed ID: 27829318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "closing-in" phenomenon in Parkinson's disease dementia and lewy-body dementia.
    Poletti M; Lucetti C; Del Dotto P; Borelli P; Baldacci F; Logi C; Bonuccelli U
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E38-9. PubMed ID: 23224479
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased driving ability in people with Parkinson's disease.
    Heikkilä VM; Turkka J; Korpelainen J; Kallanranta T; Summala H
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):325-30. PubMed ID: 9527142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of depression and Parkinson's disease on cognitive functioning.
    Norman S; Tröster AI; Fields JA; Brooks R
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):31-6. PubMed ID: 11884652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease.
    Tang H; Huang J; Nie K; Gan R; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Int J Neurosci; 2016; 126(3):227-34. PubMed ID: 26001202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.